Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Invesco S&P 500 Low Volatility ETF (SPLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Invesco S&P 500 Low Volatility ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B), while Invesco S&P 500 Low Volatility ETF trades at $72.16 (market cap $6.94B). The key difference: Invesco S&P 500 Low Volatility ETF is far larger — about 4× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is more actively traded (9,289,619 versus 1,663,703). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Invesco S&P 500 Low Volatility ETF for 123 Days on average.
| NUVB | SPLV | |
|---|---|---|
Market Cap | $1.74B | $6.94B |
Volume | 9,289,619 | 1,663,703 |
Sector | Health | — |
52-Week High | $9.54 | $77.97 |
52-Week Low | $3.41 | $70.30 |
Typical Hold Time | 1 Days | 123 Days |
Enterprise Value | $1.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPLV, the Invesco S&P 500 Low Volatility ETF, trades at $72.17 with a 1.33% daily gain. The ETF faces technical headwinds with a bearish moving average signal while oscillators remain neutral. Recent news highlights SPLV's underperformance versus the S&P 500, returning 5% versus 17%, due to sector overweights in Utilities, Real Estate, and Financials. The ETF maintains a 19.5x P/E ratio with upcoming dividend payments scheduled.
SPLV offers defensive exposure during market volatility but faces growth-adjusted valuation concerns. Key risks include concentrated sector exposure and lagging broad market performance. The neutral technical stance and mixed sentiment suggest cautious positioning for investors seeking low-volatility equity exposure amid geopolitical and economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Invesco S&P 500 Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the "index Provider") compiles, maintains and calculates the underlying index, which is designed to measure the performance of the 100 least volatile constituents of the S&P 500 ® Index over the past 12 months as determined by the index Provider.
Read more on SPLV →
